2016
Release time：2016-06-29 15:42
The phase II clinical trials of GT0918 (Proxalutamide tablets) project for prostate cancer indications have been launched in China
Suzhou Kintor has signed a MAH cooperation agreement with TOT BIOPHARM on GT0918 (Proxalutamide tablets) project
recommend News
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Powered by 300.cn